Medical News

RSS

Machine learning system may offer warnings about negative side effects of drug-drug interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death.

15 Oct 2019

ACT shows promise for treating fear of recurrence in cancer survivors

Acceptance and commitment therapy shows promise for treating fear of cancer recurrence in women who have survived breast cancer.

15 Oct 2019

Brain changes occurred independent of evolutionary rearrangements in the braincase

The human brain is about three times the size of the brains of great apes. This has to do, among other things, with the evolution of novel brain structures that enabled complex behaviors such as language and tool production.

15 Oct 2019

Inactive receptor prevents cancer drugs from reactivating the immune system

The aim of immunotherapies is to enable the immune system once again to fight cancer on its own. Drugs known as checkpoint inhibitors are already in clinical use for this purpose.

15 Oct 2019

Developing new mobile app to target victims of rural child sex trafficking

A West Virginia University School of Medicine researcher is developing an app to train key personnel in rural areas how to identify and report one of the lesser known elements of the opioid epidemic-- child sex trafficking.

15 Oct 2019

Amyloid-β protein misfolding proves to be strong risk prediction marker for Alzheimer's

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease - up to 14 years before a clinical diagnosis was made.

15 Oct 2019

BU researcher receives NIH grant for clinical research in rheumatology

David Felson, MD, MPH, professor of medicine and epidemiology at Boston University Schools of Medicine and Public Health, was awarded a National Institute of Health P30 Center Grant.

15 Oct 2019

BU receives grant to prevent and treat intimate partner violence in veteran populations

For the fourth consecutive year, the Bob Woodruff Foundation has made a grant to Boston University School of Medicine for Strength at Home, a nationwide program to prevent and treat intimate partner violence in veteran populations.

15 Oct 2019

Drug-light combination could offer better control over CAR T-cell treatments

Bioengineers at the University of California San Diego are a step closer to making CAR T-cell therapy safer, more precise and easy to control.

15 Oct 2019

Low-risk thyroid cancer and stringent follow-up: who decides?

In the case of low-risk treated thyroid cancer, some patients may be insisting on unduly intensive surveillance in the form of diagnostic scans to detect recurrence, without clear evidence for any benefit from the same, says a new study published in the Journal of Clinical Oncology.

15 Oct 2019

Mindfulness meditation appears to alter how the brain processes fear memories

Participating in an eight-week mindfulness meditation program appears to alter how the brain processes fear memories.

15 Oct 2019

Retinal macular damage linked to sleep apnea in diabetes

A new Taiwanese study presented on October 14, 2019, at the Annual Meeting of the American Academy of Ophthalmology, reports that macular edema in diabetes occurs more often in those who have severe sleep apnea.

15 Oct 2019

AI detects over 95 percent of diabetic retinopathy cases

A new study presented at the Annual Meeting of the American Academy of Ophthalmologists (AAO) on October 14, 2019 reports an astonishing 95.% yield when artificial intelligence (AI) is used to screen a real life population for diabetic retinopathy.

15 Oct 2019

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Marshall University Joan C. Edwards School of Medicine has received a five-year, $17 million award from the National Institutes of Health for continued funding of West Virginia IDeA Network of Biomedical Research Excellence.

15 Oct 2019

Heavier babies more likely to develop childhood allergies

A new study shows that babies who weigh more at any gestational age have a higher risk of later developing food allergies or eczema in childhood. However, there was no increase in the risk of hay fever. The paper published in the Journal of Allergy and Clinical Immunology found that the risk of food allergy went up by 44% and of eczema by 17% for each kilogram of added weight. On the other hand, restricted growth in the womb appears to be protective.

15 Oct 2019

New study solves oldest case of deafness in human prehistory

An international team of researchers including faculty at Binghamton University, State University of New York, has published a new study examining a 430,000-year-old cranium of a human ancestor that was previously described as deaf, representing the oldest case of deafness in human prehistory.

15 Oct 2019

Koalas protect their germline cells against retroviral attack

In a new study published in the journal Cell, scientists have found that koala DNA is protected against attack by retroviruses by a special type of immune response, which distinguishes foreign DNA from the host genome and destroys it before it can proliferate. This finding could help us understand both how koalas survive these infections, and the mechanics of adaptive gene change.

15 Oct 2019

Study explains why some people who take heart medication develop sore, aching muscles

A study from McMaster University has found a potential mechanism explaining why some people who take drugs to lower their cholesterol develop sore, aching muscles.

15 Oct 2019

Women receive poorer heart attack treatment than men

Women receive poorer heart attack treatment than men, even when rates of diagnosis are the same, according to new research funded by the British Heart Foundation (BHF) and published in the Journal of the American College of Cardiology.

15 Oct 2019

CRISPR helps find difficult to detect cancer cells

Immunotherapy is one of the latest and most effective armaments against various types of cancers. Some of the immunotherapy drugs such as PD-1 inhibitor Keytruda from Merck can block certain proteins in the cancer cells that can make the cells invisible to the immune system normally. Some of the cancers cells can now develop other ways to disguise themselves from being killed by the immune system.

15 Oct 2019